Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02742064

Enrollment

899

Registered

2016-04-18

Start date

2015-02-28

Completion date

2018-03-31

Last updated

2018-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar Disorder, Depression

Brief summary

The purpose of this study is to determine if a mobile sensing platform can passively and objectively detect the presence of clinically significant mood disorder symptomatology and symptom progression over time. Meeting this goal will allow for improved risk categorization, prediction of relapse, and measurement of disease progression in a lifetime prevalence population.

Interventions

OTHERCogito Companion Mobile Phone Application

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age 18 or older * Have a smartphone and cell service plan, including voice and data, that meets the device requirements of the Mobile Sensing Platform. * Enrolled in the MoodNetwork

Exclusion criteria

* Report positively on the QIDS-SR suicide item during study intake * Total score greater than 15 on the QIDS-SR during the screening process

Design outcomes

Primary

Measure	Time frame
Severity of MDD symptoms as assessed by QIDS SR	6 months
Severity of Mania symptoms as assessed by ASRM	6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026